New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
In laboratory and primate tests, a new pan-coronavirus vaccine developed by the Duke Human Vaccine Institute has demonstrated wide protection against SARS-CoV-2 viruses and variants, incl
Federal Grant to Duke University School of Medicine Expands HIV Research
The Duke Human Vaccine Institute(DHVI) and the Department of Surgery at Duke University School of
Unraveling the Mysteries of the Immune System
In late 2019, as the world started to hear whispers of an emerging virus in China, Priyamvada Acharya, PhD, as
Duke Human Vaccine Institute researchers study a pan vaccine for all types of coronaviruses.
Duke Human Vaccine Institute researchers are featured on the PBS NC series SCI NC and explain the work that goes into creating a vaccine that can protect us against all potential coronaviruses
Closing in on an HIV vaccine using rare antibodies
A rare type of antibody found in some individuals could help develop an HIV vaccine to target highly diverse viral strains.
Four Things to Know About Cryo-EM at Duke
The Cryo-EM microscope has taken over as the main method that Priyamvada Acharya, PhD, director of Duke's new federally funded
The Impact of Science: Duke Researcher Helps Develop Vaccines and Young Minds
Kevin Saunders explains the technology he used when COVID-19 hit, “We thought of creating a vaccine with properties that the current vaccines lacked.”
These Vaccines Will Take Aim at COVID and Its Entire SARs Lineage
Another vaccine poised to enter human clinical trials is being developed by biologist Kevin Saunders and colleagues at the Duke Human Vaccine Institute, who
While All Eyes Were on Covid, HIV Researchers Were Making Progress on “The Holy Grail of Vaccines”
Dr. Barton Haynes, Director of the Duke Human Vaccine Institute, discusses the links between COVID and finding a vaccine for HIV. Read about it in this Mother Jones article.